Patents by Inventor Michael Kuligowski

Michael Kuligowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS
    Publication number: 20260191870
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Application
    Filed: March 5, 2026
    Publication date: July 9, 2026
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • Ruxolitinib formulation for reduction of itch in atopic dermatitis
    Patent number: 12589096
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Grant
    Filed: July 21, 2025
    Date of Patent: March 31, 2026
    Assignee: Incyte Corporation
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS
    Publication number: 20250345338
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Application
    Filed: July 21, 2025
    Publication date: November 13, 2025
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • Ruxolitinib formulation for reduction of itch in atopic dermatitis
    Patent number: 12396993
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Grant
    Filed: October 28, 2022
    Date of Patent: August 26, 2025
    Assignee: Incyte Corporation
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS
    Publication number: 20230293528
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Application
    Filed: October 28, 2022
    Publication date: September 21, 2023
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • Ruxolitinib formulation for reduction of itch in atopic dermatitis
    Patent number: 11590137
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Grant
    Filed: March 28, 2022
    Date of Patent: February 28, 2023
    Assignee: Incyte Corporation
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • Ruxolitinib formulation for reduction of itch in atopic dermatitis
    Patent number: 11510923
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: November 29, 2022
    Assignee: Incyte Corporation
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS
    Publication number: 20220280518
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Application
    Filed: March 28, 2022
    Publication date: September 8, 2022
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS
    Publication number: 20210069195
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Application
    Filed: September 4, 2020
    Publication date: March 11, 2021
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee